Peptide Library / Detail
VIP
Half-life
Very short in plasma (~1–2 minutes); effects may be prolonged with localized delivery or protected formulations.
Delivery
Intranasal spray or nebulized/inhaled routes for airway studies; subcutaneous or intravenous bolus/infusion in systemic physiology models.
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Purchase
Description
VIP (Vasoactive Intestinal Peptide) is a 28–amino acid neuropeptide widely distributed in the CNS, lungs, and gut. It exerts potent vasodilatory, bronchodilatory, and immunomodulatory effects and is studied for roles in airway tone, mucosal protection, and neuroimmune signaling.
Usage
Research on airway diseases (bronchodilation, mucus regulation), gastrointestinal motility/secretions and barrier function, neuroprotection, and immune modulation (anti-inflammatory, Th2/Treg bias).
Mechanism of Action
Binds VPAC1/VPAC2 (class B GPCRs) to activate Gs→adenylate cyclase→cAMP/PKA signaling, relaxing smooth muscle, enhancing epithelial secretion, and modulating cytokines; rapidly degraded by peptidases (e.g., DPP-IV, neutral endopeptidase).
Benefits(5)
- Bronchodilation and airway smooth-muscle relaxation
- Vasodilation and improved microcirculatory flow
- Reduced pro-inflammatory cytokine signaling
- Support for epithelial barrier integrity and mucus regulation
- Neuroprotective/neuromodulatory effects in CNS models
Side Effects(5)
- Flushing and warmth
- Headache or lightheadedness
- Transient hypotension or tachycardia (dose-dependent)
- Nasal/throat irritation with intranasal or inhaled use
- GI cramping or diarrhea in sensitive subjects
VIP — frequently asked questions
What is VIP?
VIP (Vasoactive Intestinal Peptide) is a 28–amino acid neuropeptide widely distributed in the CNS, lungs, and gut. It exerts potent vasodilatory, bronchodilatory, and immunomodulatory effects and is studied for roles in airway tone, mucosal protection, and neuroimmune signaling.
What is the half-life of VIP?
VIP has an approximate half-life of Very short in plasma (~1–2 minutes); effects may be prolonged with localized delivery or protected formulations.. The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.
How is VIP administered?
VIP is typically delivered via intranasal spray or nebulized/inhaled routes for airway studies; subcutaneous or intravenous bolus/infusion in systemic physiology models.. The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.
How does VIP work?
Binds VPAC1/VPAC2 (class B GPCRs) to activate Gs→adenylate cyclase→cAMP/PKA signaling, relaxing smooth muscle, enhancing epithelial secretion, and modulating cytokines; rapidly degraded by peptidases (e.g., DPP-IV, neutral endopeptidase).
What are the researched benefits of VIP?
Studied benefits of VIP include: Bronchodilation and airway smooth-muscle relaxation, Vasodilation and improved microcirculatory flow, Reduced pro-inflammatory cytokine signaling, Support for epithelial barrier integrity and mucus regulation, Neuroprotective/neuromodulatory effects in CNS models. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.
What are the side effects of VIP?
Reported side effects of VIP include: Flushing and warmth, Headache or lightheadedness, Transient hypotension or tachycardia (dose-dependent), Nasal/throat irritation with intranasal or inhaled use, GI cramping or diarrhea in sensitive subjects. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.
Related peptides
Other peptide compounds in the Peptides Calculator library.
Sema GLP-1
Half-life · About 7 days
Oxytocin
Half-life · ≈3–5 minutes
Selank
Half-life · 3–10 minutes in plasma, longer central nervous effects
Thymosin Alpha 1
Half-life · 2 hours (approx.)
Tesofensine Powder
Half-life · Approximately 8 days
Adipotide
Half-life · 2–4 hours (in animal studies; human data not established)